Paid Clinical Trials Sandy Springs

Discover 1,004 paid clinical trials in Sandy Springs, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,004

SonelokimabA Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared with Placebo in Adult Participants with Moderate to Severe Hidradenitis Suppurativa

Recruiting

PHASE3

Sponsor:

MoonLake Immunotherapeutics AG

Location:

Sandy Springs GA, Macon GA, Nashville TN, Louisville KYshow 37 more

Code:

NCT06411899

Conditions

Hidradenitis Suppurativa

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sonelokimab

Placebo

Panosyl-IsomaltooligosaccharidesMulti-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD

Recruiting

PHASE2

Sponsor:

Microbiome Health Sciences

Location:

Sandy Springs GA, Atlanta GA, Nashville TN, Lake City FLshow 11 more

Code:

NCT05556824

Conditions

Gastroesophageal Reflux

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

MHS-1031

Placebo

LF111 vs. Non-hormonalLF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women

Recruiting

Sponsor:

Insud Pharma

Location:

Sandy Springs GA, Raleigh NC, Longwood FL, Metairie LAshow 15 more

Code:

NCT05303636

Conditions

Change in Bone Mineral Density

Bone Loss

Eligibility Criteria

Sex: Female

Age: 14 - 45

Healthy Volunteers: Accepted

Interventions

LF111 (drospirenone 4 mg oral tablet) or drospirenone (DRSP) 3.5 mg chewable tablet

CenobamateSafety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

Recruiting

PHASE3

Sponsor:

SK Life Science, Inc.

Location:

Sandy Springs GA, Augusta GA, Savannah GA, Lexington KYshow 21 more

Code:

NCT05067634

Conditions

Partial Epilepsy

Eligibility Criteria

Sex: All

Age: 2 - 18

Healthy Volunteers: Not accepted

Interventions

Xcopri

VilobelimabPhase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum

Recruiting

PHASE3

Sponsor:

InflaRx GmbH

Location:

Sandy Springs GA, Chapel Hill NC, Orlando FL, Columbus OHshow 8 more

Code:

NCT05964413

Conditions

Pyoderma Gangrenosum

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

vilobelimab

Placebo

PF-06823859A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms.

Recruiting

PHASE2

Sponsor:

Pfizer

Location:

Sandy Springs GA, Atlanta GA, Birmingham AL, Jacksonville FLshow 12 more

Code:

NCT05879718

Conditions

Lupus Erythematosus, Systemic

Lupus Erythematosus, Cutaneous

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Placebo

PF-06823859

BrensocatibA Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS)

Recruiting

PHASE2

Sponsor:

Insmed Incorporated

Location:

Sandy Springs GA, Ocala FL, Plainfield IN, Springfield OHshow 12 more

Code:

NCT06685835

Conditions

Hidradenitis Suppurativa

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Brensocatib

Placebo

Observational StudyVALOR: Vaginal Atrophy & Long-term Observation of Recovery

Recruiting

Sponsor:

Stratpharma AG

Location:

Sandy Springs GA, West Columbia SC, Charleston SC, Lake City FLshow 8 more

Code:

NCT05953090

Conditions

Atrophic Vaginitis

Vaginal Atrophy

Genitourinary Syndrome of Menopause

Lichen Sclerosus of Vulva

Lichen Planus of Vulva

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

7-0940

MF101A Study of MF101 in Postmenopausal Women

Recruiting

PHASE3

Sponsor:

Bionovo

Location:

Sandy Springs GA, Decatur GA, Smyrna TN, Columbia SCshow 43 more

Code:

NCT00906308

Conditions

Hot Flushes

Vasomotor Symptoms

Eligibility Criteria

Sex: Female

Age: 40 - 65

Healthy Volunteers: Accepted

Interventions

MF101 5 g/day

Placebo

MF101 10 g/day

RGN-259Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2

Recruiting

PHASE3

Sponsor:

ReGenTree, LLC

Location:

Sandy Springs GA, Shelby NC, Nashville TN, Lexington KYshow 28 more

Code:

NCT05555589

Conditions

Neurotrophic Keratopathy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

RGN-259

Placebo